Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Rowlands: ‘No plans’ to fix pharmacist locum rates despite ‘recent spike’

Following the news that locums working in Tesco pharmacies will be paid fixed rates from mid-July, Rowlands has clearly stated that it has “no plans to introduce flat fees for locums” working across its branches.

Last month, C+D reported that Tesco would begin paying locums working in its pharmacies one of four new set rates – capped at £36 per hour for emergency cover – from next week (July 18).

Responding to the news, Rowlands reached out to C+D to stress that it has “no plans” to set fixed locum rates for locum pharmacists covering shifts at its branches.

“We work closely with our locum colleagues and negotiate rates individually with them, which will continue,” a spokesperson for the multiple told C+D.

Meanwhile, Rowlands managing director Nigel Swift, told C+D last week (July 6) that locum pharmacists “deserve to be paid reasonable rates for the professional skills they offer”, as they are “an important part of the pharmacy network”.

 

Read more: Rowlands chief: We've had to really change how we recruit and retain pharmacy teams

 

“Wider workforce challenges” causing locum rate spike

 

However, Mr Swift noted that “in recent months, due to a nationwide shortage of pharmacists, locum rates have risen to unsustainable levels”.

These new rates “were never part of the NHS pharmacy funding cap agreed years ago”, he stated. “Therefore, we need to balance fair pay with the economic viability of keeping pharmacies open.”


Read more: Locum demand and rates ‘issue’ not isolated to pharmacy, says Maria Caulfield

 

The Rowlands spokesperson expanded on this point, noting that “wider workforce challenges” were the main cause of this “recent spike in locum rates”.

Some pharmacies have become “significantly less viable” under the pressure of paying these high locum rates and staff salaries, “alongside the substantial inflationary pressure we are all seeing”, the spokesperson said.

Such cases emphasise “the difficulty of working within a fixed funding envelope in England”, they stated.

This is “a well-known issue”, which pharmacy’s negotiating bodies “regularly” bring to the attention of “ministers, government officials and the NHS”.

 

Lloydspharmacy “constantly reviews locum rates”

 

Following Rowlands’ comments, C+D contacted Lloydspharmacy, Well Pharmacy, and Boots to understand what their plans regarding locum rates are, following Tesco’s decision.

Boots could not share a comment on this occasion, while Well Pharmacy did not respond to C+D in time for publication.

Meanwhile, a Lloydspharmacy spokesperson told C+D that the multiple “constantly [reviews its] locum rates to ensure [they] are competitive in this space”.

“Recruiting pharmacists and pharmacy teams has become increasingly difficult and it’s widely acknowledged that there are not enough pharmacists to meet demand,” they added, citing the Home Office’s placement of the pharmacist profession on its shortage occupation list.


Read more: Boots backs pharmacists’ presence on shortage occupation list

 

Providers and the NHS must step in to help pharmacy contractors address the “sector-wide workforce issues”, the spokesperson said.

Some locum pharmacists and the Pharmacists’ Defence Association have questioned whether pharmacists should be on the shortage occupation list.

 

Catch up with C+D’s Big Debate, which asked: Is there a shortage of community pharmacists?

 

 

Related Content

Topics

         
Registrant member of the Assurance and Appointments Committee 
Nationwide
£ Renumeration

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD136275

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel